Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests

Veracyte, Inc. (Nasdaq: VCYT) announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France. She will lead the global expansion of Veracyte’s tests and will also serve as site lead for the company’s Marseille operations. Dr. Taine is a highly credentialed commercial operations leader with 30 years of experience in the medical device and pharmaceutical industries. She will join Veracyte on September 19, reporting to Marc Stapley, Veracyte’s chief executive officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230907364591/en/

Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit. (Photo: Business Wire)

“Dr. Taine’s extensive international management experience and commercial leadership make her the ideal person to lead the global expansion of Veracyte’s IVD test menu. She will be key to helping us achieve our vision of transforming cancer care for patients all over the world,” said Mr. Stapley.

In the United States, Veracyte offers its market-leading tests to physicians and their patients through its centralized laboratories. The company plans to offer select tests as in vitro diagnostics (IVDs) in Europe and elsewhere so that they may be performed locally by hospitals and laboratories. Veracyte currently offers the Prosigna Breast Cancer Assay as an IVD, with additional tests in development.

Dr. Taine most recently served as vice president, Renal Care, Europe, and country sponsor, France, for Baxter International Inc., after having been president and general manager of the company’s French entity. At Baxter, she developed and managed implementation of European business plans, including Europe-wide and country-level alignment with market access and medical activities, and collaboration with the company’s European and U.S. operations. Prior to Baxter, Dr. Taine served as senior vice president of worldwide commercial operations for medical imaging company Guerbet, where she also served as president of its medical devices and French entities. She also previously served as vice president of Venous Solutions, EMEA, for Covidien, and general manager of Ultrasound Systems, France & North Africa, for Siemens Medical Solutions.